Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

Tharimmune, Inc.

GridBrain

GridBrain Sign in

GridSentinel

GridSentinel Sign in

GridAegis

GridAegis Sign in

Key Metrics

Market Snapshot

About

Tharimmune, Inc. is a clinical-stage biotechnology company developing therapeutic candidates for rare inflammatory diseases and oncology. The company focuses on novel immune-modulating therapies targeting unmet medical needs. Tharimmune advances a pipeline of product candidates through preclinical and clinical development.